1. Home
  2. NUS vs ETON Comparison

NUS vs ETON Comparison

Compare NUS & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nu Skin Enterprises Inc.

NUS

Nu Skin Enterprises Inc.

HOLD

Current Price

$6.53

Market Cap

343.1M

Sector

Health Care

ML Signal

HOLD

Logo Eton Pharmaceuticals Inc.

ETON

Eton Pharmaceuticals Inc.

HOLD

Current Price

$30.32

Market Cap

689.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NUS
ETON
Founded
1984
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Other Pharmaceuticals
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
343.1M
689.8M
IPO Year
1996
2018

Fundamental Metrics

Financial Performance
Metric
NUS
ETON
Price
$6.53
$30.32
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$39.33
AVG Volume (30 Days)
437.4K
343.5K
Earning Date
05-07-2026
05-14-2026
Dividend Yield
3.36%
N/A
EPS Growth
207.80
N/A
EPS
0.04
N/A
Revenue
$3,176,718,000.00
$79,950,000.00
Revenue This Year
N/A
$40.90
Revenue Next Year
$7.14
$47.23
P/E Ratio
$164.25
N/A
Revenue Growth
48.98
104.94
52 Week Low
$6.34
$13.09
52 Week High
$14.62
$32.31

Technical Indicators

Market Signals
Indicator
NUS
ETON
Relative Strength Index (RSI) 29.31 66.67
Support Level N/A $16.17
Resistance Level $7.50 $32.31
Average True Range (ATR) 0.28 1.52
MACD -0.09 0.26
Stochastic Oscillator 7.14 79.10

Price Performance

Historical Comparison
NUS
ETON

About NUS Nu Skin Enterprises Inc.

Nu Skin Enterprises Inc develops and distributes a comprehensive line of beauty and wellness solutions in various countries. The company operates in two primary product categories: beauty and wellness products. Additionally, the company also operates through its subsidiary, Rhyz. It reports revenue from nine segments, consisting of its seven geographic Nu Skin segments: Americas, Southeast Asia/Pacific, Mainland China, Japan, Europe & Africa, South Korea, and Hong Kong/Taiwan and two Rhyz segments: manufacturing, which includes manufacturing and packaging subsidiaries it has acquired; and Rhyz Other, which includes other investments by its Rhyz strategic investment arm. The majority of the company's revenue is generated from the Wellness product category from the Americas segment.

About ETON Eton Pharmaceuticals Inc.

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.

Share on Social Networks: